Gracia Lifesciences India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -99.93%
(FY 2023)
- Profit -3887.15%
(FY 2023)
- Ebitda -663.93%
(FY 2023)
- Net Worth -203.74%
(FY 2023)
- Total Assets -10.74%
(FY 2023)
About Gracia Lifesciences India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyanka Dua and Ashwani Mehta serve as directors at the Company.
- CIN/LLPIN
U24232CH2012PTC034012
- Company No.
034012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gracia Lifesciences India Private Limited offer?
Gracia Lifesciences India Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Anti Infective Drugs & Medicines, Antibacterial Drugs, Antibiotic Injection, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Ayurvedic Powder and Medicinal Herbs.
Who are the key members and board of directors at Gracia Lifesciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Dua  | Director | 21-Dec-2015 | Current |
| Ashwani Mehta | Director | 23-Aug-2012 | Current |
Financial Performance of Gracia Lifesciences India.
Gracia Lifesciences India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.93% decrease. The company also saw a substantial fall in profitability, with a 3887.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 203.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gracia Lifesciences India?
In 2023, Gracia Lifesciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sap Biotech India Private LimitedActive 10 years 4 monthsPriyanka Dua and Ashwani Mehta are mutual person
Asterisk Laboratories India Private LimitedActive 10 years 11 monthsPriyanka Dua and Ashwani Mehta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gracia Lifesciences India?
Unlock and access historical data on people associated with Gracia Lifesciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gracia Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gracia Lifesciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
